NC(=O)c1ncn([C@@H]2O[C@H](CNCc3cc(Br)ccc3OCc3ccccc3)[C@@H](O)[C@H]2O)n1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?